arb

(redirected from Angiotensin II receptor antagonist)
Also found in: Dictionary, Medical, Financial, Encyclopedia, Wikipedia.
Related to Angiotensin II receptor antagonist: ACE inhibitor, calcium channel blocker
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for arb

someone who engages in arbitrage (who purchases securities in one market for immediate resale in another in the hope of profiting from the price differential)

References in periodicals archive ?
The angiotensin II receptor antagonist candesartan cilexetil is widely used in the treatment of hypertension.
Angiotensin II receptor antagonists generally are very well tolerated antihypertensive drugs, but they should be considered as a potential cause of acute reactions, even in patients who have taken them for years.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing primarily to the generic availability of the angiotensin II receptor antagonist (AIIRA) and the AIIRA/hydrochlorothiazide fixed dose combination (FDC) drug classes, the hypertension drug market will decline from approximately $26 billion in 2010 to $20.
Nephropathy in Type 2 Diabetic Patients: The Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan (RENAAL) study was a randomized, placebo-controlled, double-blind, multicenter study conducted worldwide in 1513 patients with type 2 diabetes with nephropathy (defined as serum creatinine 1.
President: Takakazu Morita) announced preliminary results of the overseas clinical trials of two drug candidates for lowering intraocular pressure in glaucoma and ocular hypertension: an angiotensin II receptor antagonist, DE-092 (INN: Olmesartan), and a prostaglandin derivative, DE-085 (INN: Tafluprost).
Other ethical drugs in the Takeda line include candesartan cilexetil, an angiotensin II receptor antagonist.
Boehringer Ingelheim and Yamanouchi also cooperate in Japan to co-promote MICARDIS(R) monotherapy (generic name telmisartan), an angiotensin II receptor antagonist discovered and developed by Boehringer Ingelheim for the treatment of hypertension.
During the November 2001 American Heart Association Meeting in Anaheim, Boehringer Ingelheim announced the initiative for nine additional studies involving their angiotensin II receptor antagonist telmisartan (Micardis(R)), many of which have already started.
Angiotensin II receptor antagonists have less adverse effects than ACE inhibitors, but may still cause xerostomia, taste alteration and orthostatic hypotension.
It should be used with caution in women on other medications that can increase potassium, including NSAIDs, potassium-sparing diuretics, ACE inhibitors, or angiotensin II receptor antagonists.
Candesartan prevents the narrowing of veins and arteries and is in the class of drugs called angiotensin II receptor antagonists.
Full browser ?